Marker Therapeutics (MRKR) Notes Payables (2010 - 2018)
Marker Therapeutics (MRKR) reported Notes Payables of $5000.0 for Q3 2018, little changed year-over-year from $5000.0 in Q3 2017, and little changed quarter-over-quarter from $5000.0 in Q2 2018.
Marker Therapeutics (MRKR) Notes Payables (2010 - 2018) Analysis & Trends
Marker Therapeutics (MRKR) has 9 years of Notes Payables data on file, last reported at $5000.0 in Q3 2018.
- Notes Payables for Q3 2018 came in at $5000.0, changed 0.0% year-over-year; the trailing twelve-month figure through Sep 2018 was $5000.0 (changed 0.0% YoY), and the FY2017 annual result was $5000.0, changed 0.0% from the prior year.
- Notes Payables steadied at $5000.0 in Q3 2018 per MRKR's latest filing, from $5000.0 in the prior quarter.
- Over five years, Notes Payables peaked at $434533.0 in Q1 2014 and troughed at $5000.0 in Q1 2016.
- A 5-year average of $44956.3 and a median of $5000.0 in 2016 frame the typical range for Notes Payables.
- The sharpest annual moves came in 2016 and 2017: Notes Payables sank 90.56% in 2016, then changed 0.0% in 2017.
- A 5-year view of Notes Payables shows it stood at $52942.0 in 2014, then sank by 56.56% to $23000.0 in 2015, then plunged by 78.26% to $5000.0 in 2016, then changed by 0.0% to $5000.0 in 2017, then changed by 0.0% to $5000.0 in 2018.
- Business Quant data shows MRKR's Notes Payables at $5000.0 in Q3 2018, $5000.0 in Q2 2018, and $5000.0 in Q1 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - |
| 10 | Marker Therapeutics | 28.20 Mn | 28.20 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2018 | 5,000.00 |
| Jun 30, 2018 | 5,000.00 |
| Mar 31, 2018 | 5,000.00 |
| Dec 31, 2017 | 5,000.00 |
| Sep 30, 2017 | 5,000.00 |
| Jun 30, 2017 | 5,000.00 |
| Mar 31, 2017 | 5,000.00 |
| Dec 31, 2016 | 5,000.00 |
| Jun 30, 2016 | 5,000.00 |
| Mar 31, 2016 | 5,000.00 |
| Dec 31, 2015 | 23,000.00 |
| Sep 30, 2015 | 52,942.00 |
| Jun 30, 2015 | 52,942.00 |
| Mar 31, 2015 | 52,942.00 |
| Dec 31, 2014 | 52,942.00 |
| Mar 31, 2014 | 434,533.00 |
| Dec 31, 2013 | 369,000.00 |
| Sep 30, 2013 | 2.35 Mn |
| Mar 31, 2013 | 2.25 Mn |
| Dec 31, 2012 | 1.48 Mn |